1
|
Kanis JA, McCloskey EV, Harvey NC,
Johansson H and Leslie WD: Intervention thresholds and the
diagnosis of osteoporosis. J Bone Miner Res. 30:1747–1753.
2015.PubMed/NCBI View Article : Google Scholar
|
2
|
Khosla S, Atkinson EJ, Melton LJ III and
Riggs BL: Effects of age and estrogen status on serum parathyroid
hormone levels and biochemical markers of bone turnover in women: A
population-based study. J Clin Endocrinol Metab. 82:1522–1527.
1997.PubMed/NCBI View Article : Google Scholar
|
3
|
Vidal M, Thibodaux RJ, Neira LFV and
Messina OD: Osteoporosis: A clinical and pharmacological update.
Clin Rheumatol. 38:385–395. 2019.PubMed/NCBI View Article : Google Scholar
|
4
|
Marx RE: Pamidronate (Aredia) and
zoledronate (Zometa) induced avascular necrosis of the jaws: A
growing epidemic. J Oral Maxillofac Surg. 61:1115–1117.
2003.PubMed/NCBI View Article : Google Scholar
|
5
|
McClung M, Harris ST, Miller PD, Bauer DC,
Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK and Lewiecki EM:
Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug
holiday. Am J Med. 126:13–20. 2013.PubMed/NCBI View Article : Google Scholar
|
6
|
Deligiorgi MV and Trafalis DT: The safety
profile of denosumab in oncology beyond the safety of denosumab as
an anti-osteoporotic agent: Still more to learn. Expert Opin Drug
Saf. 20:191–213. 2021.PubMed/NCBI View Article : Google Scholar
|
7
|
Akiyama K, Chen C, Wang D, Xu X, Qu C,
Yamaza T, Cai T, Chen W, Sun L and Shi S:
Mesenchymal-stem-cell-induced immunoregulation involves
FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell.
10:544–555. 2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Tang WY, Liu JH, Peng CJ, Liao Y, Luo JS,
Sun X, Tang YL and Luo XQ: Functional characteristics and
application of mesenchymal stem cells in systemic lupus
erythematosus. Arch Immunol Ther Exp (Warsz). 69(7)2021.PubMed/NCBI View Article : Google Scholar
|
9
|
Barati S, Tahmasebi F and Faghihi F:
Effects of mesenchymal stem cells transplantation on multiple
sclerosis patients. Neuropeptides. 84(102095)2020.PubMed/NCBI View Article : Google Scholar
|
10
|
Miura M, Gronthos S, Zhao M, Lu B, Fisher
LW, Robey PG and Shi S: SHED: Stem cells from human exfoliated
deciduous teeth. Proc Natl Acad Sci USA. 100:5807–5812.
2003.PubMed/NCBI View Article : Google Scholar
|
11
|
Sakai VT, Zhang Z, Dong Z, Neiva KG,
Machado MA, Shi S, Santos CF and Nör JE: SHED differentiate into
functional odontoblasts and endothelium. J Dent Res. 89:791–796.
2010.PubMed/NCBI View Article : Google Scholar
|
12
|
Chadipiralla K, Yochim JM, Bahuleyan B,
Huang CY, Garcia-Godoy F, Murray PE and Stelnicki EJ: Osteogenic
differentiation of stem cells derived from human periodontal
ligaments and pulp of human exfoliated deciduous teeth. Cell Tissue
Res. 340:323–333. 2010.PubMed/NCBI View Article : Google Scholar
|
13
|
Yamaza T, Kentaro A, Chen C, Liu Y, Shi Y,
Gronthos S, Wong S and Shi S: Immunomodulatory properties of stem
cells from human exfoliated deciduous teeth. Stem Cell Res Ther.
1(5)2010.PubMed/NCBI View
Article : Google Scholar
|
14
|
Yang N, Liu X, Chen X, Yu S, Yang W and
Liu Y: Stem cells from exfoliated deciduous teeth transplantation
ameliorates Sjögren's syndrome by secreting soluble PD-L1. J Leukoc
Biol: Oct 8, 2021 (Epub ahead of print).
|
15
|
Kitase Y, Sato Y, Ueda K, Suzuki T,
Mikrogeorgiou A, Sugiyama Y, Matsubara K, Tsukagoshi Okabe Y,
Shimizu S, Hirata H, et al: A novel treatment with stem cells from
human exfoliated deciduous teeth for hypoxic-ischemic
encephalopathy in neonatal rats. Stem Cells Dev. 29:63–74.
2020.PubMed/NCBI View Article : Google Scholar
|
16
|
Li W, Jiao X, Song J, Sui B, Guo Z, Zhao
Y, Li J, Shi S and Huang Q: Therapeutic potential of stem cells
from human exfoliated deciduous teeth infusion into patients with
type 2 diabetes depends on basal lipid levels and islet function.
Stem Cells Transl Med. 10:956–967. 2021.PubMed/NCBI View Article : Google Scholar
|
17
|
Liu Y, Wang L, Liu S, Liu D, Chen C, Xu X,
Chen X and Shi S: Transplantation of SHED prevents bone loss in the
early phase of ovariectomy-induced osteoporosis. J Dent Res.
93:1124–1132. 2014.PubMed/NCBI View Article : Google Scholar
|
18
|
Mita T, Furukawa-Hibi Y, Takeuchi H,
Hattori H, Yamada K, Hibi H, Ueda M and Yamamoto A: Conditioned
medium from the stem cells of human dental pulp improves cognitive
function in a mouse model of Alzheimer's disease. Behav Brain Res.
293:189–197. 2015.PubMed/NCBI View Article : Google Scholar
|
19
|
Bartholomew A, Sturgeon C, Siatskas M,
Ferrer K, McIntosyu K, Patil S, Hardy W, Devine S, Ucker D, Deans
R, et al: Mesenchymal stem cells suppress lymphocyte proliferation
in vitro and prolong skin graft survival in vivo. Exp Hematol.
30:42–48. 2002.PubMed/NCBI View Article : Google Scholar
|
20
|
He Q, Wang L, Zhao R, Yan F, Sha S, Cui C,
Song J, Hu H, Guo X, Yang M, et al: Mesenchymal stem cell-derived
exosomes exert ameliorative effects in type 2 diabetes by improving
hepatic glucose and lipid metabolism via enhancing autophagy. Stem
Cell Res Ther. 11(223)2020.PubMed/NCBI View Article : Google Scholar
|
21
|
Li T, Yan Y, Wang B, Qian H, Zhang X, Shen
L, Wang M, Zhou Y, Zhu W, Li W and Xu W: Exosomes derived from
human umbilical cord mesenchymal stem cells alleviate liver
fibrosis. Stem Cells Dev. 22:845–854. 2013.PubMed/NCBI View Article : Google Scholar
|
22
|
Lubura M, Hesse D, Neumann N, Scherneck S,
Wiedmer P and Schürmann A: Non-invasive quantification of white and
brown adipose tissues and liver fat content by computed tomography
in mice. PLoS One. 7(e37026)2012.PubMed/NCBI View Article : Google Scholar
|
23
|
Fathi E, Farahzadi R and Valipour B:
Alginate/gelatin encapsulation promotes NK cells differentiation
potential of bone marrow resident C-kit+ hematopoietic
stem cells. Int J Biol Macromol. 177:317–327. 2021.PubMed/NCBI View Article : Google Scholar
|
24
|
Komori T: Animal models for osteoporosis.
Eur J Pharmacol. 759:287–294. 2015.PubMed/NCBI View Article : Google Scholar
|
25
|
Fathi E, Farahzadi R, Vietor I and
Javanmardi S: Cardiac differentiation of bone-marrow-resident
c-kit+ stem cells by L-carnitine increases through
secretion of VEGF, IL6, IGF-1, and TGF-β as clinical agents in
cardiac regeneration. J Biosci. 45(92)2020.PubMed/NCBI
|
26
|
Pacifici R: Estrogen deficiency, T cells
and bone loss. Cell Immunol. 252:68–80. 2008.PubMed/NCBI View Article : Google Scholar
|
27
|
Fischer V and Haffner-Luntzer M:
Interaction between bone and immune cells: Implications for
postmenopausal osteoporosis. Semin Cell Dev Biol: May 20, 2021
(Epub ahead of print).
|
28
|
Cenci S, Toraldo G, Weitzmann MN, Roggia
C, Gao Y, Qian WP, Sierra O and Pacifici R: Estrogen deficiency
induces bone loss by increasing T cell proliferation and lifespan
through IFN-gamma-induced class II transactivator. Proc Natl Acad
Sci USA. 100:10405–10410. 2003.PubMed/NCBI View Article : Google Scholar
|
29
|
Gao Y, Grassi F, Ryan MR, Terauchi M, Page
K, Yang X, Weitzmann MN and Pacifici R: IFN-gamma stimulates
osteoclast formation and bone loss in vivo via antigen-driven T
cell activation. J Clin Invest. 117:122–132. 2007.PubMed/NCBI View
Article : Google Scholar
|
30
|
Zhao R: Immune regulation of bone loss by
Th17 cells in oestrogen-deficient osteoporosis. Eur J Clin Invest.
43:1195–1202. 2013.PubMed/NCBI View Article : Google Scholar
|
31
|
Tyagi AM, Srivastava K, Mansoori MN,
Trivedi R, Chattopadhyay N and Singh D: Estrogen deficiency induces
the differentiation of IL-17 secreting Th17 cells: A new candidate
in the pathogenesis of osteoporosis. PLoS One.
7(e44552)2012.PubMed/NCBI View Article : Google Scholar
|
32
|
Bhadricha H, Patel V, Singh AK, Savardekar
L, Patil A, Surve S and Desai M: Increased frequency of Th17 cells
and IL-17 levels are associated with low bone mineral density in
postmenopausal women. Sci Rep. 11(16155)2021.PubMed/NCBI View Article : Google Scholar
|
33
|
Kovacic N, Grcevic D, Katavic V, Lukic IK,
Grubisic V, Mihovilovic K, Cvija H, Croucher PI and Marusic A: Fas
receptor is required for estrogen deficiency-induced bone loss in
mice. Lab Invest. 90:402–413. 2010.PubMed/NCBI View Article : Google Scholar
|
34
|
Murray PJ and Wynn TA: Protective and
pathogenic function of macrophage subsets. Nat Rev Immunol.
11:723–737. 2011.PubMed/NCBI View
Article : Google Scholar
|
35
|
Lu LY, Loi F, Nathan K, Lin TH, Pajarinen
J, Gibon E, Nabeshima A, Cordova L, Jämsen E, Yao Z and Goodman SB:
Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal
stem cells via the COX-2-prostaglandin E2 pathway. J Orthop Res.
35:2378–2385. 2017.PubMed/NCBI View Article : Google Scholar
|
36
|
Sica A and Mantovani A: Macrophage
plasticity and polarization: In vivo veritas. J Clin Invest.
122:787–795. 2012.PubMed/NCBI View Article : Google Scholar
|
37
|
Liu Q, Tian Y, Zhao X, Jing H, Xie Q, Li
P, Li D, Yan D and Zhu X: NMAAP1 expressed in BCG-activated
macrophage promotes M1 macrophage polarization. Mol Cells.
38:886–894. 2015.PubMed/NCBI View Article : Google Scholar
|
38
|
van Dalen FJ, van Stevendaal MHME,
Fennemann FL, Verdoes M and Ilina O: Molecular repolarisation of
tumour-associated macrophages. Molecules. 24(9)2018.PubMed/NCBI View Article : Google Scholar
|
39
|
Mills CD: M1 and M2 macrophages: Oracles
of health and disease. Crit Rev Immunol. 32:463–488.
2012.PubMed/NCBI View Article : Google Scholar
|
40
|
Hiraki T, Kunimatsu R, Nakajima K, Abe T,
Yamada S, Rikitake K and Tanimoto K: Stem cell-derived conditioned
media from human exfoliated deciduous teeth promote bone
regeneration. Oral Dis. 26:381–390. 2020.PubMed/NCBI View Article : Google Scholar
|
41
|
Ando Y, Matsubara K, Ishikawa J, Fujio M,
Shohara R, Hibi H, Ueda M and Yamamoto A: Stem cell-conditioned
medium accelerates distraction osteogenesis through multiple
regenerative mechanisms. Bone. 61:82–90. 2014.PubMed/NCBI View Article : Google Scholar
|